Annual Accounts Payable
$8.93 M
-$1.02 M-10.26%
December 31, 2023
Summary
- As of February 7, 2025, AQST annual accounts payable is $8.93 million, with the most recent change of -$1.02 million (-10.26%) on December 31, 2023.
- During the last 3 years, AQST annual accounts payable has risen by +$1.84 million (+25.91%).
- AQST annual accounts payable is now -56.32% below its all-time high of $20.44 million, reached on December 31, 2018.
Performance
AQST Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$7.57 M
+$1.88 M+32.94%
September 30, 2024
Summary
- As of February 7, 2025, AQST quarterly accounts payable is $7.57 million, with the most recent change of +$1.88 million (+32.94%) on September 30, 2024.
- Over the past year, AQST quarterly accounts payable has dropped by -$2.42 million (-24.23%).
- AQST quarterly accounts payable is now -62.95% below its all-time high of $20.44 million, reached on December 31, 2018.
Performance
AQST Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AQST Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.3% | -24.2% |
| 3 y3 years | +25.9% | -24.2% |
| 5 y5 years | -56.3% | -24.2% |
AQST Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.3% | +7.4% | -39.1% | +32.9% |
| 5 y | 5-year | -27.3% | +25.9% | -39.1% | +32.9% |
| alltime | all time | -56.3% | +34.5% | -63.0% | +32.9% |
Aquestive Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.57 M(+32.9%) |
| Jun 2024 | - | $5.70 M(-45.9%) |
| Mar 2024 | - | $10.52 M(+17.9%) |
| Dec 2023 | $8.93 M(-10.3%) | $8.93 M(-10.7%) |
| Sep 2023 | - | $9.99 M(-6.5%) |
| Jun 2023 | - | $10.69 M(-14.1%) |
| Mar 2023 | - | $12.44 M(+25.1%) |
| Dec 2022 | $9.95 M(+19.6%) | $9.95 M(-10.2%) |
| Sep 2022 | - | $11.07 M(+24.6%) |
| Jun 2022 | - | $8.89 M(+4.6%) |
| Mar 2022 | - | $8.50 M(+2.2%) |
| Dec 2021 | $8.31 M | $8.31 M(+33.8%) |
| Sep 2021 | - | $6.21 M(-23.3%) |
| Jun 2021 | - | $8.10 M(+21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $6.69 M(-5.7%) |
| Dec 2020 | $7.09 M(-42.2%) | $7.09 M(-22.7%) |
| Sep 2020 | - | $9.17 M(+4.3%) |
| Jun 2020 | - | $8.79 M(-14.5%) |
| Mar 2020 | - | $10.28 M(-16.2%) |
| Dec 2019 | $12.27 M(-39.9%) | $12.27 M(-13.6%) |
| Sep 2019 | - | $14.20 M(-29.1%) |
| Jun 2019 | - | $20.03 M(+4.6%) |
| Mar 2019 | - | $19.14 M(-6.3%) |
| Dec 2018 | $20.44 M(+112.9%) | $20.44 M(+65.6%) |
| Sep 2018 | - | $12.34 M(-25.3%) |
| Jun 2018 | - | $16.52 M(+50.4%) |
| Mar 2018 | - | $10.99 M(+14.5%) |
| Dec 2017 | $9.60 M(+44.6%) | $9.60 M |
| Dec 2016 | $6.64 M | - |
FAQ
- What is Aquestive Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual accounts payable year-on-year change?
- What is Aquestive Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly accounts payable year-on-year change?
What is Aquestive Therapeutics annual accounts payable?
The current annual accounts payable of AQST is $8.93 M
What is the all time high annual accounts payable for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual accounts payable is $20.44 M
What is Aquestive Therapeutics annual accounts payable year-on-year change?
Over the past year, AQST annual accounts payable has changed by -$1.02 M (-10.26%)
What is Aquestive Therapeutics quarterly accounts payable?
The current quarterly accounts payable of AQST is $7.57 M
What is the all time high quarterly accounts payable for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly accounts payable is $20.44 M
What is Aquestive Therapeutics quarterly accounts payable year-on-year change?
Over the past year, AQST quarterly accounts payable has changed by -$2.42 M (-24.23%)